DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Müller N, Ulmschneider M, Scheppach C. et al.
COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy.
Eur Arch Psychiatry Clin Neurosci 2004; 254: 14-22
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.